Interim report
Page 1
GRIFOLS 15 YEARS STOCK MARKET 2006-2021 First Half 2021 Results Free translation from the original in Spanish . In the event of discrepancy , the Spanish language version will prevail . The Bioscience Division grows 5.1 % in the second quarter and raises first - half revenues to EUR 2,537 million Net income increased by 22 % to EUR 267 million Revenues in the second quarter grew 5.3 % cc¹ to EUR 1,352 million due to solid performance of the Bioscience , Diagnostic and Hospital Divisions . 1 Bioscience revenues increased 5.1 % cc in the quarter and increase first - half revenues to EUR 1,986 million . Of note is the positive contribution of new products and the increase in prices of certain proteins . The Diagnostic and Hospital Divisions recorded double - digit growth , attaining EUR 395 million ( 22.9 % cc ) and EUR 68 million ( 19.5 % cc ) in revenues , respectively . EBITDA totals EUR 635 million ( a 9.4 % increase ) , 25.0 % over sales . Grifols ' financial debt ratio decreases to 4.9x . The strategic agreement with GIC will further reduce it by 0.6x . Plasma collections in the U.S. continue to rise , while collections in Europe exceed pre - pandemic levels leveraging on recent acquisitions and multiple initiatives . Barcelona , July 29 , 2021.- Grifols ( MCE : GRF , MCE : GRF .P , NASDAQ : GRFS ) reported 2.3 % cc ( -5.3 % taking into account exchange rate variations ) growth and EUR 2,536.6 million in revenues in the first half , a period marked by the gradual recovery of plasma donations , debt reduction , and significant investment efforts to further consolidate plasma supply levels and innovation . In the second quarter of 2021 , revenues grew by 5.3 % cc to EUR 1,351.9 million , fueled by the solid performance of the Bioscience , Diagnostic and Hospital divisions . The Bioscience Division recorded notable 5.1 % cc growth , reversing the 5.6 % cc decline recorded in the first quarter . First - half revenues totaled EUR 1,986.0 million ( -0.1 % cc ; -8.0 % ) . Operating or constant currency ( cc ) excludes changes rate variations reported in the period .